Avidity Biosciences Director Disposes of Over $3.8 Million in Company Stock
In a recent major transaction, Arthur A. Levin, a director at Avidity Biosciences, Inc. (NASDAQ:RNA), sold a substantial number of shares from his portfolio. The sales, conducted on June 12 and June 13, 2024, totaled 100,000 shares of common stock, yielding over $3.8 million in value.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
